Ardelyx (ARDX) Revenue (2013 - 2026)
Ardelyx (ARDX) posted Revenue of $94.5 million for Q1 2026, down 24.55% on a QoQ basis from $125.2 million in Q4 2025, and up 27.47% year-over-year from $74.1 million in Q1 2025.
Ardelyx (ARDX) Revenue (2013 - 2026) Analysis & Trends
Ardelyx's Revenue history runs 12 years deep, the most recent figure standing at $94.5 million for Q1 2026.
- Quarterly Revenue rose 27.47% year-over-year to $94.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $320.8 million (down 11.32% YoY) and the FY2025 annual result came in at $407.3 million, up 22.09% from the prior year.
- Revenue was $94.5 million for Q1 2026 at Ardelyx, down from $125.2 million in the prior quarter.
- Across five years, Revenue topped out at $125.2 million in Q4 2025 and bottomed at $468000.0 in Q1 2022.
- A 5-year average of $53.2 million and a median of $46.0 million in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue soared 4193.29% — and 2025, when it tumbled 96.54%.
- Ardelyx's Revenue stood at $44.2 million in 2022, then slipped by 22.22% to $34.4 million in 2023, then soared by 237.95% to $116.1 million in 2024, then rose by 7.82% to $125.2 million in 2025, then decreased by 24.55% to $94.5 million in 2026.
- Business Quant data shows ARDX's Revenue at $94.5 million in Q1 2026, $125.2 million in Q4 2025, and $3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ardelyx | 1.24 Bn | 999.81 Mn | 89.66 Mn | 94.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.47 Mn |
| Dec 31, 2025 | 125.22 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 97.66 Mn |
| Mar 31, 2025 | 74.11 Mn |
| Dec 31, 2024 | 116.13 Mn |
| Sep 30, 2024 | 98.24 Mn |
| Jun 30, 2024 | 73.22 Mn |
| Mar 31, 2024 | 46.02 Mn |
| Dec 31, 2023 | 34.36 Mn |
| Sep 30, 2023 | 56.39 Mn |
| Jun 30, 2023 | 22.33 Mn |
| Mar 31, 2023 | 11.37 Mn |
| Dec 31, 2022 | 44.18 Mn |
| Sep 30, 2022 | 4.99 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 468,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 1.31 Mn |